Business·Industry

Peptron, Inc. Applies for Building Modification Permit for Osong Plant No. 2… Total Floor Area to Be Expanded by 2.5 Times

Reflecting the Expansion of Production and Support Facilities… Contractor to Be Selected After Permission Is Granted

KIM SAE-MI
2026-07-24 15:44:02
Exterior view of Peptron, Inc.’s Daejeon headquarters (Photo courtesy of Peptron, Inc.)

[Edaily Reporter KIM SAE-MI ] Peptron ( Peptron, Inc.(087010)) announced on the 24th that it has applied for a building modification permit to reflect design changes aimed at expanding production and support facilities at its Osong Bio Park Plant No. 2.

According to the proposed changes, the total floor area of Plant No. 2 will be expanded 2.5 times, from the current approximately 12,000 square meters to approximately 30,000 square meters. The company expects that expanding the plant’s scale will enhance the utilization of its production and support facilities.

Peptron, Inc. is proceeding with follow-up procedures, such as selecting a construction contractor, alongside the permit amendment process. Future key developments will be disclosed in accordance with relevant laws and regulations. However, specific design details and facility configurations were not disclosed.

A Peptron, Inc. official stated, “Since the detailed design specifications and facility configuration related to the building modification permit constitute commercially sensitive information tied to the company’s production technology and operational strategy, it is difficult to disclose specific details,” adding, “We will continue to provide updates on matters that can be disclosed, within the scope of compliance with relevant laws and regulations.”

Economy

Corporation

IT·Science

Economy

From Buildings to Operating Companies… Rental Housing Platforms Swallowed Whole

The way global private equity fund (PEF) managers invest in rental housing is evolving. Previously, most cases involved directly purchasing individual properties. However, transactions have recently e…
2026-08-11 00:34:03

Corporation

SK hynix Responds to Rumors of Chongqing Plant Stake Sale: "Nothing Has Been Finalized"

SK hynix has drawn a clear line regarding reports that it is pursuing the sale of its stake in its Chongqing, China, plant, stating, “Nothing has been finalized.” This is the company’s response to a r…
2026-08-10 18:53:57

IT·Science

Medy-Tox Inc. Reports 11% Increase in Second-Quarter Revenue… ‘NewViju’ Emerges as New Growth Engine

Medy-Tox Inc.(086900)Medytox continued its revenue growth in the second quarter of this year, driven by expanded overseas sales of botulinum toxin and dermal fillers, as well as the successful market …
2026-08-10 17:02:01